HealthTree Logo
search more_vert

Clinical Expertise

  • Chronic Lymphocytic Leukemia
  • Waldenstrom's Macroglobulinemia
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
  • Leukemia
  • Idiopathic Thrombocytopenic Purpura


Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.


Weill Cornell Medical Center: 428 E 72nd St #300, New York, NY 10021, USA

Get the latest thought leadership on CLL delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.